The current CVLB market cap is 1.12B. The company's latest EPS is USD -0.6241 and P/E is -16.36.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 31.41M | 33.22M | 33.13M | 35.95M | 38.61M |
Operating Income | -6.82M | -7.88M | -2.85M | -4.9M | -4.57M |
Net Income | -8.06M | -12.71M | -4.79M | -7.51M | -6.9M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 12.47M | 37.29M | 92.88M | 124.14M | 152.55M |
Operating Income | -2.89M | -57.82M | -54.3M | -43.45M | -14.49M |
Net Income | -3.14M | -63.36M | -61.77M | -48.64M | -23.7M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 33.36M | 25.67M | 33.87M | 35.45M | 40.69M |
Total Liabilities | 30.28M | 32.97M | 41.23M | 45.65M | 51.78M |
Total Equity | -1.37M | -11.87M | -12.04M | -15.24M | -11.08M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 3.45M | 13.05M | 49.92M | 25.67M | 58.48M |
Total Liabilities | 4.58M | 13.88M | 24.1M | 32.97M | 52.92M |
Total Equity | -1.13M | -4.48M | 21.71M | -11.87M | 5.57M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -20.97M | -22.94M | -2.61M | 2.03M | 3.11M |
Investing | -12.13M | -13.91M | -1.81M | -4.11M | -6.52M |
Financing | -2.39M | -528k | 11.99M | 10.03M | 14.74M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 252k | -12.13M | -33.09M | -22.94M | 8.82M |
Investing | -100k | -798k | -3.4M | -13.91M | -8.73M |
Financing | 775k | 21M | 68.64M | -528k | 29.1M |
Market Cap | 1.12B |
Price to Earnings Ratio | -16.36 |
Price to Sales Ratio | 2.54 |
Price to Cash Ratio | 11.7 |
Price to Book Ratio | 69.67 |
Dividend Yield | - |
Shares Outstanding | 37.98M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.83 (2.78%) |
Company Name | Conversion Labs Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://lifemd.com |
Industry | manufacturing industries,nec (3999) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.